Perspective
Published on 03 May 2022
An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.863101
- 5,596 views
- 6 citations
195 Publications
volumes
Volume 2 - 2022
Editorial
Published on 25 Apr 2022
Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.904502
- 1,480 views
Original Research
Published on 14 Apr 2022
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.850414
- 16,994 views
- 6 citations
Original Research
Published on 07 Apr 2022
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.829138
- 3,105 views
- 2 citations
Review
Published on 25 Mar 2022
The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.853475
- 11,094 views
- 35 citations
Review
Published on 21 Mar 2022
18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.847810
- 15,679 views
- 11 citations
Case Report
Published on 15 Mar 2022
Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.858062
- 3,636 views
- 2 citations
Review
Published on 08 Mar 2022
F-18 Fluoro-2-Deoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Melanoma: Normal Variants, Pitfalls, and Artifacts
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.835404
- 3,979 views
- 4 citations
Review
Published on 03 Mar 2022
Normal Variants and Pitfalls of 18F-FDG PET/CT Imaging in Pediatric Oncology
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.825891
- 11,620 views
- 11 citations
Mini Review
Published on 25 Feb 2022
Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.801792
- 3,618 views
- 6 citations
Review
Published on 21 Feb 2022
Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT Imaging
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.825512
- 29,270 views
- 16 citations
Case Report
Published on 16 Feb 2022
Case Report: Skeletal Muscle Lymphoma as a Result of Slow Centrifugal Migration of Untreated Primary Neurolymphomatosis?
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.804421
- 2,314 views
Original Research
Published on 14 Feb 2022
Estimation of the Internal Dose Imparted by 18F-Fluorodeoxyglucose to Tissues by Using Fricke Dosimetry in a Phantom and Positron Emission Tomography
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.815141
- 5,032 views
- 2 citations
Review
Published on 07 Feb 2022
Normal Variants, Pitfalls and Artifacts in Ga-68 DOTATATE PET/CT Imaging
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.825486
- 34,062 views
- 17 citations
Volume 1 - 2021
Review
Published on 22 Feb 2022
18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.808627
- 6,835 views
- 10 citations
Review
Published on 01 Feb 2022
Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.826046
- 10,030 views
- 4 citations
Review
Published on 21 Jan 2022
Shared Decision Making for Radioiodine Therapy and the Actual Pattern of Care in Intermediate-Risk Differentiated Thyroid Carcinoma
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.797522
- 2,745 views
- 1 citation
Original Research
Published on 20 Jan 2022
Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonylation as Exemplified by the Radiolabeling of Inhibitors of Bruton's Tyrosine Kinase
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.820235
- 6,870 views
- 11 citations
Review
Published on 17 Jan 2022
F-18 FDG PET/CT Imaging in Normal Variants, Pitfalls and Artifacts in the Abdomen and Pelvis
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.826109
- 28,578 views
- 14 citations
Review
Published on 06 Jan 2022
Amino Acid and Proliferation PET/CT for the Diagnosis of Multiple Myeloma
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.796357
- 3,205 views
- 3 citations
Case Report
Published on 14 Dec 2021
Case Report: Pleuropulmonary Blastoma in a 2.5-Year-Old Boy: 18F-FDG PET/CT Findings
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.780485
- 3,592 views
- 5 citations
Original Research
Published on 13 Dec 2021
Optimization and Evaluation of Al18F Labeling Using a NOTA—or RESCA1-Conjugated AE105 Peptide Antagonist of uPAR
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.799533
- 4,291 views
- 4 citations
Original Research
Published on 30 Nov 2021
Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid Cancer Patients at Intermediate-High Risk of Recurrence
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.785768
- 3,009 views
- 3 citations
Original Research
Published on 18 Nov 2021
Fully Automated 68Ga-Labeling and Purification of Macroaggregated Albumin Particles for Lung Perfusion PET Imaging
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2021.778191
- 5,198 views
- 7 citations